Company news

Twist Bioscience Corporation news in 2026

Twist Bioscience Corporation's news releases, calls and decks from 2026, newest first.

View company

Notice of Proposed Derivative Settlement: Twist Bioscience Corporation

November 3, 2026

Twist Bioscience Launches MRD Express with Rapid Turnaround Time

October 29, 2026

Twist Bioscience Expands High-Throughput Antibody Characterization with Launch of Express Screening Antibodies

October 28, 2026

Twist Bioscience to Report Fiscal 2026 Fourth Quarter and Full Year Financial Results on Thursday, November 12, 2026

October 26, 2026

Twist Bioscience Joins Lilly TuneLab to Advance Antibody Drug Discovery

September 16, 2026

Twist Bioscience Corporation Announces Inducement Grants under NASDAQ Listing Rule 5635(4)

August 5, 2026

Twist Bioscience Announces Pricing of Upsized $300.0 Million Public Offering of Common Stock

August 4, 2026

Twist Bioscience Announces Fiscal 2026 Third Quarter Financial Results

August 3, 2026

Twist Bioscience to Report Fiscal 2026 Third Quarter Financial Results on Monday, August 3, 2026

July 15, 2026

Twist Bioscience to Present at William Blair 46th Annual Growth Stock Conference

May 27, 2026

LenioBio and Twist Bioscience Enter into a Collaboration to Further Enable AI drug-discovery

May 8, 2026

Benchling Launches One-Click Ordering for Biopharma R&D with Twist Bioscience, Adaptyv, and Ginkgo Bioworks

May 6, 2026

Twist Bioscience Expands Clonal Genes Offering to Include Long and Complex Sequences

May 4, 2026

Twist Bioscience Announces Fiscal 2026 Second Quarter Financial Results

May 4, 2026

Twist Bioscience to Report Fiscal 2026 Second Quarter Financial Results on Monday, May 4, 2026

April 21, 2026

Twist Bioscience Expands Antibody Discovery Offering with Bispecific Licensing Agreement

February 17, 2026

Twist Bioscience Launches Next-Generation Library Preparation Kits Powered by Proprietary Enzymes

February 10, 2026

Twist Bioscience Corporation Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4)

February 2, 2026

Twist Bioscience Announces Fiscal 2026 First Quarter Financial Results

February 2, 2026

Twist Bioscience Announces Preliminary First Quarter Fiscal 2026 Revenue

January 11, 2026

Calls in 2026

Decks in 2026